Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer.
Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L. · 2023
Read Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. by Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc10196327.txt.
Introduction
Xue and co-authors review new understanding of the JAK-STAT signaling pathway in a 2023 paper, with a focus on autoimmune disease and cancer. The pathway carries signals from outside a cell to its genes, switching on responses to hormones, growth factors, and immune messengers. It is ancient, shared across animals, and central to blood and immune function.
The review maps how faults in the pathway drive disease when signals run too hot or too cold. It surveys drugs that block JAK enzymes, now used in arthritis and cancer care, and what may come next.
Catalog record
| CREATOR | Xue C, Yao Q, Gu X, Shi Q, Yuan X, Chu Q, Bao Z, Lu J, Li L. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 182 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |